Login to Your Account



Financing Roundup

Aposense Completes IPO, Gets $24M for Apoptosis Programs

By Catherine Hollingsworth


Tuesday, June 8, 2010
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription